
Do we need to consider inflammatory markers when we treat atherosclerotic disease?
Keywords: بیماری خودایمنی; Cardiovascular disease; Non-alcoholic fatty liver disease; Autoimmune disease; Inflammation; C-reactive protein; Statins; Angiotensin II blockade